Survival for Young Patients with Diffuse Large B-Cell Lymphoma Improved by Ibrutinib
source: pixabay.com

Survival for Young Patients with Diffuse Large B-Cell Lymphoma Improved by Ibrutinib

According to a recent article, new evidence shows adding ibrutinib to a patient’s chemotherapy regimen may improve the longevity of younger patients with diffuse large B-cell lymphoma (DLBCL). Diffuse Large…

Continue Reading Survival for Young Patients with Diffuse Large B-Cell Lymphoma Improved by Ibrutinib
Minimal Change Disease Research Supported by Discovery of Autoantibodies Attacking Nephrin
jarmoluk / Pixabay

Minimal Change Disease Research Supported by Discovery of Autoantibodies Attacking Nephrin

According to a recent article, patients diagnosed with minimal change disease are found to have autoantibodies targeting nephrin, which supports previous research. Minimal Change Disease (MCD) Minimal change disease is…

Continue Reading Minimal Change Disease Research Supported by Discovery of Autoantibodies Attacking Nephrin

Castle Creek Biosciences Expands Their Cell and Gene Therapy Platform By Acquiring Novavita Thera Inc.

According to a recent article, Castle Creek Inc. has acquired Novavita Thera Inc. in an effort to expand its research and development efforts. Castle Creek Inc. Castle Creek Biosciences Inc.…

Continue Reading Castle Creek Biosciences Expands Their Cell and Gene Therapy Platform By Acquiring Novavita Thera Inc.

Study Shows Promising Results for Radiotherapy to Treat Oligometastatic Renal Cell Carcinoma

According to a recent article from MedPage Today, the results from a small prospective study show that sequential radiotherapy (RT) is successful in delaying systemic therapy for oligometastatic renal cell…

Continue Reading Study Shows Promising Results for Radiotherapy to Treat Oligometastatic Renal Cell Carcinoma
Promising Results from Clinical Trial for Stem-Cell-Based Gene Therapy for Beta-Thalassemia
Belova59 / Pixabay

Promising Results from Clinical Trial for Stem-Cell-Based Gene Therapy for Beta-Thalassemia

According to a recent article, a new stem-cell-based gene therapy is showing promising results for treating beta (β)-thalassemia in a phase 1 clinical trial. Beta Thalassemia Beta thalassemia is a…

Continue Reading Promising Results from Clinical Trial for Stem-Cell-Based Gene Therapy for Beta-Thalassemia
Gene Therapy Reduces Need for Transfusions in Patients with Beta-Thalassemia
source: pixabay.com

Gene Therapy Reduces Need for Transfusions in Patients with Beta-Thalassemia

According to a recent article, a study shows that treatment with gene therapy reduces the need for patients with non-β0/ β0 genotype Beta-thalassemia (β-thalassemia)to get transfusions. Beta-thalassemia (β-thalassemia) Beta thalassemia…

Continue Reading Gene Therapy Reduces Need for Transfusions in Patients with Beta-Thalassemia
An Opportunity for Junior Investigators to Make an Impact on PAH Research
https://pixabay.com/photos/student-notebook-female-study-type-865073/

An Opportunity for Junior Investigators to Make an Impact on PAH Research

The Pulmonary Hypertension Association recently announced it is offering junior investigators who are interested in pulmonary arterial hypertension (PAH) a two-year grant. Pulmonary Arterial Hypertension (PAH) Pulmonary arterial hypertension (PAH)…

Continue Reading An Opportunity for Junior Investigators to Make an Impact on PAH Research
Study Shows New Gene Therapy Technique Successful in Reversing Severe Hearing Loss in Mice
source: pixabay.com

Study Shows New Gene Therapy Technique Successful in Reversing Severe Hearing Loss in Mice

According to a recent article, a new study from Boston Children’s Hospital shows that a first-of-its-kind gene therapy technique has succeeded in reversing severe hearing loss from a mutation to…

Continue Reading Study Shows New Gene Therapy Technique Successful in Reversing Severe Hearing Loss in Mice